Provides announced that it offers filed an investigational fresh drug program with the U.

BioMarin documents investigational NDA for PEG-PAL for the treating phenylketonuria BioMarin Pharmaceutical Inc. Provides announced that it offers filed an investigational fresh drug program with the U cialis på nettet http://www.cialisnorge.eu/ .S. Food and Medication Administration for PEG-PAL , known as Phenylase formerly, for the treating phenylketonuria . The business expects to initiate a medical study of PEG-PAL in PKU sufferers in the first one fourth of 2008. ‘Submitting this IND is usually a significant milestone in the advancement of our PEG-PAL plan and our overall dedication to aid the PKU community,’ stated Jean-Jacques Bienaime, CEO of BioMarin.